Automated cervical cancer screening using a smartphone AI classifier

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to improve cervical cancer screening in low- and middle-income countries by utilizing a smartphone-based artificial intelligence classifier called AVC. The AVC system records two-minute videos of the cervix during visual inspection with acetic acid (VIA) and analyzes them using an artificial neural network to provide objective classifications. This approach seeks to enhance the accuracy of VIA, which is currently dependent on the healthcare provider's experience. The collaboration involves the Gynecology and Obstetrics Department of the Geneva University Hospital and the Swiss Institute of Technology.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Free and informed consent to take part in the study on a voluntary basis

Exclusion Criteria:

* No initiation of sexual intercourse
* Pregnancy at the screening consultation
* Any condition altering the cervix visualization at the screening consultation (e.g. heavy vaginal bleeding)
* History of anogenital cancer or known anogenital cancer at the screening consultation
* Previous hysterectomy
* Not sufficiently healthy to participate in the study

Where it's running

• Dschang District Hospital
  Dschang, Menoua, Cameroon Recruiting

Study contacts

• Principal investigator: Patrick Petignat — University Hospital, Geneva
• Study coordinator: Patrick Petignat, Pr
• Email: patrick.petignat@hcuge.ch
• Phone: +41796630546

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• CHW4CervixHealth: HPV self-collection kits with community health workers

  This project will test whether giving self-collection HPV kits during community workshops led by community health workers helps increase screening among under-screened women aged 25–65 and will first compare kit results to clinical Pap smears.

  Recruiting Thomas Jefferson University · Philadelphia, Pennsylvania · NCT07336134

• Treatment approaches for HPV-related lesions in women

  This study looks at whether getting vaccinated after surgery for HPV-related lesions can help reduce the chances of women developing cervical dysplasia or cancer later on.

  Recruiting Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · Milan, Lombardy · NCT05938192

• mSaada mobile app to support HPV-based cervical screening and follow-up

  This project will test whether the mSaada mobile app helps community health volunteers in Kenya increase HPV screening and ensure women aged 30–65 get follow-up and treatment.

  Recruiting Duke University · Kisumu, Kisumu County · NCT05848557

• Cervical screening and care options for women living with HIV who test positive for high-risk HPV

  This study tests different ways to screen and manage high-risk HPV in women with HIV to see what might work best for them.

  Recruiting University of California, San Diego · Nairobi · NCT07925307

• Hydrogel spacer to protect the rectum during cervical cancer radiotherapy

  This study tests whether placing an absorbable hydrogel spacer between the cervix/vagina and rectum before definitive radiotherapy can reduce rectal radiation exposure for women with cervical cancer.

  Recruiting Tianjin Medical University Cancer Institute and Hospital · Tianjin, Tianjin Municipality · NCT07904182

• How cinema sessions during chemotherapy might help cervical cancer patients

  We’re testing if watching films during chemotherapy helps cervical cancer patients feel less anxious and improve quality of life.

  Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Roma · NCT07902180

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.